Active8: a randomized, double-blind, placebo-controlled study of chemotherapy plus cetuximab in combination with TLR8 agonist VTX-2337 in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN)

Detalles Bibliográficos
Autores principales: Ferris, Robert L, Cohen, Ezra, Gash, Kelly, Whiting, Sam, Manjarrez, Kristi, Dietsch, Greg, Hershberg, Robert, Bryan, James Kyle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288723/
http://dx.doi.org/10.1186/2051-1426-2-S3-P69

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288723/
http://dx.doi.org/10.1186/2051-1426-2-S3-P69

Ejemplares similares